If you are:
Only When Necessary: INSUFFICIENT HUMAN DATA; ANIMAL DATA SUGGEST DEVELOPMENTAL TOXICITY
Precaution: LOW LEVELS EXCRETED; MFR SUGGESTS DELAYING NURSING FOR 12 HOURS AFTER DOSE
An adult over 60:
management or monitoring precaution: Hepatic-Elderly patients are more likely to have decreased hepatic function thus decreasing drug clearance. Cardiovascular-Hypertensive effects may be more pronounced in the elderly and increase the risk for cardiovascular events in those with cardiovascular disease. A cardiovascular evaluation is recommended in those with CV risk factors, Avoid use of the drug in any patient with a cerebrovascular syndrome.
Giving sumatriptan-succinate to a child under 12:
Severe Precaution: Efficacy not established over placebo for treatment of migraine. Adverse event risk similar to adults including visual loss and stroke.